These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7828627)

  • 21. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Radionuclide purity of 99mTC eluate for use in nuclear medicine].
    Vucina JL
    Med Pregl; 1996; 49(1-2):41-4. PubMed ID: 8643069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diversification of 99Mo/99mTc separation: non–fission reactor production of 99Mo as a strategy for enhancing 99mTc availability.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2015 Jan; 56(1):159-61. PubMed ID: 25537991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simple new method for effective concentration of 188Re solutions from alumina-based 188W-188Re generator.
    Guhlke S; Beets AL; Oetjen K; Mirzadeh S; Biersack HJ; Knapp FF
    J Nucl Med; 2000 Jul; 41(7):1271-8. PubMed ID: 10914921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some remarks on 99Mo-99mTc generator kinetics.
    Husak V; Vlcek J
    Eur J Nucl Med; 1982; 7(7):331-2. PubMed ID: 7117276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Essentials of a rubidium-82 generator for nuclear medicine.
    Yano Y
    Int J Rad Appl Instrum A; 1987; 38(3):205-11. PubMed ID: 3034827
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclotron production of NCA 99mTc and 99Mo. An alternative non-reactor supply source of instant 99mTc and 99Mo----99mTc generators.
    Lagunas-Solar MC; Kiefer PM; Carvacho OF; Lagunas CA; Cha YP
    Int J Rad Appl Instrum A; 1991; 42(7):643-57. PubMed ID: 1663097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Assay of radioactive impurity in 99mTc-pertechnetate eluted from 99Mo-99mTc generator (author's transl)].
    Saegusa K; Arimizu N; Nakata T; Tohyama H; Shiina I
    Radioisotopes; 1980 Feb; 29(2):94-6. PubMed ID: 7384574
    [No Abstract]   [Full Text] [Related]  

  • 29. Development of a 99Mo/99mTc generator using alumina microspheres for industrial radiotracer applications.
    Dash A; Chakravarty R; Ram R; Pillai KT; Yadav YY; Wagh DN; Verma R; Biswas S; Venkatesh M
    Appl Radiat Isot; 2012 Jan; 70(1):51-8. PubMed ID: 21820904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radionuclides and radiopharmaceuticals for single-photon emission tomography, positron emission tomography and radiotherapy in Russia.
    Krasikova RN; Kodina GE
    Eur J Nucl Med; 1999 Jul; 26(7):774-88. PubMed ID: 10398826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radioactive impurities in 99Mo-99mTc generator eluate (author's transl)].
    Amano R; Mori H; Sanada S; Ando A; Maeda T; Hiraki T; Hisada K
    Kaku Igaku; 1980 Jul; 17(5):601-6. PubMed ID: 7420766
    [No Abstract]   [Full Text] [Related]  

  • 32. Short- and long-term responses to molybdenum-99 shortages in nuclear medicine.
    Ballinger JR
    Br J Radiol; 2010 Nov; 83(995):899-901. PubMed ID: 20965898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromine-82 contamination in fission product 99mTc-generator eluate.
    McAuley R; Lull R; Ice R
    Eur J Nucl Med; 1985; 10(1-2):60-2. PubMed ID: 3979411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Production and Clinical Applications of Radiopharmaceuticals and Medical Radioisotopes in Iran.
    Jalilian AR; Beiki D; Hassanzadeh-Rad A; Eftekhari A; Geramifar P; Eftekhari M
    Semin Nucl Med; 2016 Jul; 46(4):340-58. PubMed ID: 27237443
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Technetium generator log form.
    Vernig PG
    Health Phys; 2001 Aug; 81(2 Suppl):S11-2. PubMed ID: 11480855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of reaction conditions for the radiolabeling of DOTA and DOTA-peptide with (44m/44)Sc and experimental evidence of the feasibility of an in vivo PET generator.
    Huclier-Markai S; Kerdjoudj R; Alliot C; Bonraisin AC; Michel N; Haddad F; Barbet J
    Nucl Med Biol; 2014 May; 41 Suppl():e36-43. PubMed ID: 24361353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 14 MeV Neutrons for
    Capogni M; Pietropaolo A; Quintieri L; Angelone M; Boschi A; Capone M; Cherubini N; De Felice P; Dodaro A; Duatti A; Fazio A; Loreti S; Martini P; Pagano G; Pasquali M; Pillon M; Uccelli L; Pizzuto A
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30060449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fission-Produced
    Youker AJ; Chemerisov SD; Tkac P; Kalensky M; Heltemes TA; Rotsch DA; Vandegrift GF; Krebs JF; Makarashvili V; Stepinski DC
    J Nucl Med; 2017 Mar; 58(3):514-517. PubMed ID: 27688474
    [No Abstract]   [Full Text] [Related]  

  • 39. An 225Ac/213Bi generator system for therapeutic clinical applications: construction and operation.
    McDevitt MR; Finn RD; Sgouros G; Ma D; Scheinberg DA
    Appl Radiat Isot; 1999 May; 50(5):895-904. PubMed ID: 10214708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Generator-produced yttrium-90 for radioimmunotherapy.
    Chinol M; Hnatowich DJ
    J Nucl Med; 1987 Sep; 28(9):1465-70. PubMed ID: 3625298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.